Gregory d. Perry

Gregory d. Perry is a declared insider at 2 companies (board member); the most frequent names are KALA BIO, Inc. and Ocata Therapeutics, Inc. We count 7 filings; the first trade dates from 31 December 2015 and the latest from 15 June 2025.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 17 June 2025 with a share grant in KALA BIO, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.